Ledger.Open graph →
SEC Form D · filed July 10, 2020

Artiva Biotherapeutics, Inc

Offering
$78.4M
Sold
$43.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Yvonne J. Yamanaka · San Diego, CADirectorEsther J. Van Den Boom · San Diego, CAExecYu-Kyeong J. Hwang · San Diego, CADirectorLaura J. Stoppel · San Diego, CADirectorJason J. Litten · San Diego, CAExecPeter J. Flynn · San Diego, CAExecBrian J. Daniels · San Diego, CADirectorYong-Jun J. Huh · San Diego, CADirectorThomas J. Farrell · Houston, TXExec · DirectorYu-Kyeong J. Hwang · San Diego, CADirectorYvonne J. Yamanaka · San Diego, CADirectorLaura J. Stoppel · San Diego, CADirectorJason J. Litten · San Diego, CAExecPeter J. Flynn · San Diego, CAExecEsther J. Van Den Boom · San Diego, CAExecBrian J. Daniels · San Diego, CADirectorYong-Jun J. Huh · San Diego, CADirectorThomas J. Farrell · San Diego, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗